Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update

Area of Science:

• Neurology
• Immunology
• Biochemistry

Background:

• Multiple sclerosis (MS) is a complex immune-mediated CNS disease with varied clinical presentations.
• Accurate diagnosis of MS is challenging due to disease heterogeneity and evolving diagnostic criteria.
• Cerebrospinal fluid (CSF) analysis is crucial for evaluating CNS inflammation and immunological changes in MS.

Purpose of the Study:

• To review current knowledge on CSF biomarkers for MS diagnosis.
• To discuss validated assays and alternative biomarkers for detecting intrathecal synthesis.
• To highlight the role of novel biomarkers in improving MS diagnostics.

Main Methods:

• Review of scientific literature on CSF biomarkers in MS.
• Analysis of diagnostic criteria and laboratory findings for MS.
• Evaluation of established methods like oligoclonal band (OCB) detection.
• Assessment of emerging biomarkers such as free light chains (FLCs).

Main Results:

• Oligoclonal bands (OCBs) in CSF and serum are the gold standard for MS laboratory diagnosis but have limitations.
• Current OCB assays are time-consuming and operator-dependent.
• Quantification of CSF free light chains (FLCs) shows promise as an alternative diagnostic biomarker for MS.

Conclusions:

• CSF biomarkers are fundamental for MS diagnosis and monitoring.
• Limitations exist with current gold standard methods for OCB detection.
• Free light chain (FLC) quantification in CSF represents a valuable advancement in MS diagnostic approaches.